Prometrium
PreclinicalSmall molecule
Prometrium is one of 10 small molecule programs targeting Frozen Embryo Transfer. It is currently in Preclinical.
2
Indications
4
Total Trials
0
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
7 competitors in Progesterone
#DrugCompanyPhaseTrials
1Prometrium
FerringApproved
Micronized Progesterone
AAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Phase 3
Activella
Eli LillyPreclinical
Ulipristal Acetate
AbbViePreclinical
Prometrium
SSolvay Pharmaceuticals
Preclinical
Estrace
UUniversity of Virginia
Preclinical
Dydrogesterone Pill
NNational University of Malaysia
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Pregnant Women1 trial
Safety and Efficacy1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Prometrium. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SSolvay Pharmaceuticals